¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : °­µ¿°æÈñ´ëÇб³º´¿ø º°°üµ¿ 4Ãþ Â÷ÈÄ¿µÈ¦

±³À°ÁÖÁ¦ : 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : °­µ¿°æÈñ´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºñ´¢±â°ú

´ã´çÀÚ : ÃÖżö
¿¬¶ôó : 010-9870-1702

À̸ÞÀÏ : taesoochoi85@hanmail.net

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 15:30~16:00 RIRS: how to optimize outcome & minimize complication for a novice °­Áø¼®(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 16:00~16:30 ¿ä°ü°ú ½ÅÀå ÁúȯÀÇ ÃֽŠ¼ö¼ú Æ®·»µå Á¤¸® ÀÌÁ¤¿ì(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 16:30~17:00 Multi-system-level analysis approach to identify biomarkers for ccRCC / prostate cancer ±è¸¸¼®(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 17:00~17:30 ÀΰøÁö´É ½ºÄ³³Ê ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ Á¦ºê¶óÇǽ¬ Áúȯ¸ðµ¨ ÀÚµ¿ Ç¥ÇöÇü ½ºÅ©¸®´× Ç÷§Æû ÀÌÀ±¼º(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 17:45~18:15 Recent updates in the management of acute prostatitis ÃÖÁ¤Çõ(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 18:15~18:45 Interpretation of chronic prostatitis as pathologic results after prostate biopsy Ãֽ±Ç(¼­¿ïÀÇ·á¿ø)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 18:45~19:15 Alternative treatments for male LUTS ±èµ¿¼ö(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ °­µ¿°æÈñ´ëº´¿ø Â÷ÈÄ¿µÈ¦(º°°ü4Ãþ) 19:15~19:45 ED¸¦ µ¿¹ÝÇÑ male LUTS ȯÀÚ¿¡¼­ PDE5i À¯Áö¿ë¹ýÀÇ È¿°ú ÃÖżö(°æÈñÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ - Á¦68Â÷ Ãá°èÇмú´ëȸ (3ÀÏÂ÷) : 2024-04-20
´ÙÀ½±Û 2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20634 ´ëÀü 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 10 2024-05-10
20633 ¼­¿ï ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18 0 18 2024-05-10
20632 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17 0 7 2024-05-10
20631 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 0 4 2024-05-10
20630 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (1ÀÏÂ÷) : 2024-05-17 0 6 2024-05-10
20629 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ¿Â¶óÀÎ_¼­¿ï°æÀÎÁöȸ 276Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-17 0 2 2024-05-10
20628 ¼­¿ï 2024³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-17 0 8 2024-05-10
20627 ´ëÀü ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ´ëÀüÁöȸ ¿¬¼ö±³À° : 2024-05-17 0 13 2024-05-10
20626 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 12 2024-05-10
20625 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõ) : 2024-05-13 0 8 2024-05-10
20624 ¼­¿ï ´ëÇÑ·¹ÀÌÀúÇǺθð¹ßÇÐȸ Á¦46Â÷ Ãá°è Çмú´ëȸ : 2024-05-12 0 8 2024-05-10
20623 ¼­¿ï Á¦2ȸ ´ëÇѽŰæ°úÀÇ»çȸ Ãá°è ÀçÅÃÀÇ·á ½ÉÆ÷Áö¾ö : 2024-05-12 0 20 2024-05-10
20622 ´ë±¸ Á¦54ȸ ´ëÇѵΰæºÎ¿Ü°úÇÐȸ Áõ·ÊÇмú´ëȸ : 2024-05-11 0 9 2024-05-10
20621 °æºÏ 2024³â Á¦28ȸ ´ëÇÑÀü¸³¼±·¹ÀÌÀú¿¬±¸ÇÐȸ ÁýÁß½ÉÆ÷Áö¾ö : 2024-05-10 0 7 2024-05-10
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 163 2024-04-30
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷